ArticleHeliyon2023

Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer.

Sai Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.